Aimei Net Income from 2010 to 2026

AFJK Stock   52.60  0.11  0.21%   
Aimei Health Net Income yearly trend continues to be quite stable with very little volatility. The value of Net Income is projected to decrease to about 1.5 M. From the period between 2010 and 2026, Aimei Health, Net Income regression line of its data series had standard deviation of  887,430 and standard deviation of  887,430. View All Fundamentals
 
Net Income  
First Reported
2010-12-31
Previous Quarter
2.9 M
Current Value
1.5 M
Quarterly Volatility
887.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Aimei Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aimei Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.9 K, Other Operating Expenses of 1.3 M or Total Operating Expenses of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.06. Aimei financial statements analysis is a perfect complement when working with Aimei Health Valuation or Volatility modules.
Check out the analysis of Aimei Health Correlation against competitors.
Historical Net Income data for Aimei Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Aimei Health Technology represents a compelling investment opportunity.

Latest Aimei Health's Net Income Growth Pattern

Below is the plot of the Net Income of Aimei Health Technology over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aimei Health Technology financial statement analysis. It represents the amount of money remaining after all of Aimei Health Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aimei Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aimei Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.55 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Aimei Net Income Regression Statistics

Arithmetic Mean552,007
Geometric Mean269,726
Coefficient Of Variation160.76
Mean Deviation626,899
Median171,389
Standard Deviation887,430
Sample Variance787.5B
Range2.8M
R-Value0.62
Mean Square Error520.2B
R-Squared0.38
Significance0.01
Slope108,430
Total Sum of Squares12.6T

Aimei Net Income History

20261.5 M
20252.9 M
20242.6 M

Other Fundumenentals of Aimei Health Technology

About Aimei Health Financial Statements

Aimei Health investors utilize fundamental indicators, such as Net Income, to predict how Aimei Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Income2.9 M1.5 M
Net Income From Continuing Ops2.3 MM
Net Income Per Share 0.25  0.27 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Aimei Health Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Aimei Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Aimei Health Technology Stock. Highlighted below are key reports to facilitate an investment decision about Aimei Health Technology Stock:
Check out the analysis of Aimei Health Correlation against competitors.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aimei Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.2
Return On Assets
(0.01)
Understanding Aimei Health Technology requires distinguishing between market price and book value, where the latter reflects Aimei's accounting equity. The concept of intrinsic value—what Aimei Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aimei Health's price substantially above or below its fundamental value.
Understanding that Aimei Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aimei Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aimei Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.